Human tissue factor clotting compound and preparation method thereof

A tissue factor and complex technology, applied in the field of human tissue factor coagulation complex, can solve the problems of lack of cytokine secretion and platelet recruitment, single function of thrombin, etc., to promote wound healing, efficient coagulation activity, and easy operation. Effect

Active Publication Date: 2019-02-01
厦门宏谱福生物科技有限公司
View PDF5 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Active local hemostatic materials have the advantage of rapid onset of effect. For extensive wound bleeding, local spraying can be used for hemostasis without compression and packing. However, the function of thrombin is single, there is no cascade amplification effect of coagulation factors, and the necessary cells in the coagulation pathway are lacking. Role of factor secretion and platelet recruitment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human tissue factor clotting compound and preparation method thereof
  • Human tissue factor clotting compound and preparation method thereof
  • Human tissue factor clotting compound and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] (1) Cell membrane localization detection of tTF-PHLIP fusion protein in cells: HEK293T cells stably expressing tTF-PHLIP fusion protein were cultured in a confocal dish with DMEM medium containing 10% fetal bovine serum and appropriate amount of antibiotics, When the cells adhere to the wall and the confluence reaches about 50%, aspirate the culture medium, wash it carefully with PBS, fix the cells with 4% paraformaldehyde for 15 minutes, soak in PBS for 3 times; permeabilize with 0.5% Triton X-100 at room temperature for 20 minutes, Soak and wash 3 times; drop a sufficient amount of diluted rabbit-derived anti-tissue factor primary antibody, incubate at 37°C for 1 hour, soak and wash 3 times with PBS; drop a sufficient amount of diluted fluorescence-conjugated anti-rabbit antibody secondary antibody , incubate at 37°C for 1 hour, soak in PBS for 3 times; add DAPI (4',6-diamidino-2-phenylindole dihydrochloride) dropwise and incubate in the dark for 5 minutes, stain the n...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a human tissue factor clotting compound and a preparation method thereof. The compound has a local rapid hemostatic function, has the effects of wound infection prevention, wound healing promotion and the like, and has a composite effect different from a conventional local clotting agent. The clotting compound disclosed by the invention is simple to prepare, is applied to rapid hemostasis, antibiosis and wound healing promotion of local known or unknown hemorrhagic spots in operations and epidermis wounds and tissue epidermis wounds caused by trauma, and has advantagesin applications for treating liver injury, articular cartilage injury, eye injury, diabetes, hemophilia and the like.

Description

technical field [0001] The invention relates to a human tissue factor coagulation complex. Background technique [0002] Bleeding is a very common situation in people's daily life and medical procedures, especially in surgery. Whether intraoperative hemostasis is fast and effective directly affects the prognosis of patients. The bleeding problem in the medical treatment of special patients such as diabetes and hemophilia is particularly difficult, so it is very important It is necessary to develop more effective hemostatic drugs with more diverse functions. Hemostatic strategies for intraoperative bleeding mainly include mechanical hemostasis, systemic application of hemostatic drugs, and local hemostatic drugs. [0003] Mechanical hemostasis is the most widely used clinical method and the simplest method, mainly including ligation, suture, electrocoagulation, packing and other methods, but in addition to gauze packing, the bleeding point must be clear before operation, for...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/867A61K38/36A61P7/04
CPCA61K38/00A61P7/04C07K14/745C07K2319/00C12N15/86C12N2740/15043
Inventor 刘刚李文岗苗逢霖林惠荣
Owner 厦门宏谱福生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap